Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
EASTS study of antiplatelet discontinuation strategies after sirolimus-eluting stent implantation
ChiCTR-TRC-10001056Phase 4Completed
- Sponsor
- Zhejiang University
- Start
- Mar 2011
- Modality
- Orthosteric Ligands → Classical Binding Small Molecules → Small Molecules, Small Molecules
- Countries
- 1
01
Overview
Phase 4, randomised, double-blind trial of clopidogrel and aspirin in coronary arteriosclerosis (3 arms), sponsored by Zhejiang University. Primary endpoint: Major adverse cardiovascular events. Started Mar 2011; status: completed.
02
Drugs
clopidogrelaspirin
03
Conditions
coronary arteriosclerosis
Beyond the preview
Go deeper on ChiCTR-TRC-10001056.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on ChiCTR-TRC-10001056.